Jewish General Hospital Virtual Medical Grand Rounds

JEWISH GENERAL HOSPITAL
DEPARTMENT OF MEDICINE
MONDAY MEDICAL GRAND ROUNDS ON ZOOM

The Medical Grand Rounds are an accredited group learning activity as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

Some Rounds were video recorded.

Medical Grand Rounds 2020-2021

1:00-2:00 PM

April 26, 2021

KIDNEY DISEASE IN THE ERA OF GENOMIC MEDICINE
Thomas Kitzler, MD
Assistant Professor of Human Genetics
McGill University
Division of Medical Genetics
McGill University Health Centre & Jewish General Hospital         
Educational Objectives:
At the conclusion of this activity, participants will be able to:
1. Recognize when to consider genetic testing in patients with kidney disease
2. List the most common genetic causes of kidney disease
3. Give examples of how genetic testing may influence treatment and management in patients with kidney disease
Contact Person: David Rosenblatt, MD, Division of Medical Genetics, Department of Specialized Medicine, Tel. 514-340-8222 ext. 23428.
Press on the “control” key and click on the following link to join this Microsoft Teams meeting, Join on your computer or mobile app
 Click here to join the meeting

April 19, 2021

50% + 1: CURRENT STATE AND FUTURE OF TAVR, AND THE JGH EXPERIENCE
Ali Abu Al Saud, MD
Assistant Professor of Medicine, McGill University
Division of Cardiology, Jewish General Hospital
Nathan Messas, MD
Assistant Professor of Medicine, McGill University
Division of Cardiology, Jewish General Hospital
Emmanuel Moss, MD
Assistant Professor of Surgery at McGill University
Director, Division of Cardiac Surgery, Jewish General Hospital
Lawrence Rudski, MD
Professor of Medicine, McGill University
Chief, Division of Cardiology, Jewish General Hospital
Director, Azrieli Heart Center
Educational Objectives:
1. Review current evidence for TAVR (transcatheter aortic valve replacement) in low, medium and high risk patients
2. Learn the work-up and evaluation process in patient selection and technical procedures associated with valve implantation
3. Review JGH results in the first 2 years of the program
4. See how a nascent program can lead in quality and innovation
Contact Person: Lawrence Rudski, MD, Chief, Division of Cardiology and Director, Azrieli Heart Center, Tel. 514-340-8222 ext. 22992.
Press on the “control” key and click on the following link to join this Microsoft Teams meeting, Join on your computer or mobile app
 Click here to join the meeting

April 12, 2021

AEROSOL TRANSMISSION OF INFECTIOUS AGENTS
Raymond Tellier, MD
Associate Professor of Medicine, McGill University
Division of Medical Microbiology, Royal Victoria Hospital, CUSM
Educational Objectives:
1. Understand the nature and physical behavior of aerosols
2. Understand the concept of anisotropic infection
3. Become aware of aerosol transmission of influenza and SARS-CoV-2 viruses
Contact Person: Karl Weiss, MD, Chief, Division of Infectious Diseases, Tel. 514-340-8222 ext. 28294.
Press on the “control” key and click on the following link to join this Microsoft Teams meeting , Join on your computer or mobile app
 Click here to join the meeting

April 5, 2021

No Rounds - Easter Monday

March 29, 2021

Passover - No rounds

March 22, 2021

MARCH, DVT AWARENESS MONTH
THROMBOSIS AND ANTICOAGULATION RESEARCH IN THE TIME OF COVID-19: GLOBAL TRIALS AND LOCAL LEADERS
Ryan Zarychanski, MD

Associate Professor of Medicine and Pharmacology
Sections of Hematology/Medical Oncology and Critical Care
University of Manitoba, Winnipeg, Canada

Vicky Tagalakis, MD, FRCPC. MSc
Associate Professor, Department of Medicine, and Director of General Internal Medicine
McGill University

& Maral Koolian, MD
Assistant Professor, Department of Medicine
McGill University

Educational Objectives:
1.To discuss the ATTACC (Antithrombotic Therapy to Ameliorate Complications of COVID) trial, including unique trial features (adaptive design, multiplatform trial)
2. To highlight JGH and McGill leadership in COVID thrombosis research
Contact Person:  Susan Kahn, MD, Division of Internal Medicine, Tel. 514-340-8222 extension 24667.
Press on the “control” key and click on the following link to join this Microsoft Teams meeting:  Join live event

March 15, 2021

PULMONARY GENETICS: MOVING FROM THE LAB TO THE CLINIC
Benjamin Raby, MD, MPH

Leila and Irving Perlmutter Professor of Pediatrics, Harvard Medical School
Chief, Division of Pulmonary Medicine, Boston Children’s Hospital
Director, Pulmonary Genetics Center, Brigham and Women’s Hospital

Educational Objectives:
1. Learn how genetics influence a variety of common and less common respiratory diseases
2. To understand how genetic information is currently being used for the evaluation and management of patients with a wide range of respiratory diseases
3. To understand how genetic information can play a role in disease detection and early intervention in asymptomatic at-risk relatives of patients with respiratory disease
Contact Person: Carmela Pepe, MD, Division of Pulmonary Medicine, Tel. 514-340-7900.
Press on the “control” key and click on the following link to join this Microsoft Teams meeting:  Join live event

March 8, 2021

TREATING SUBCLINICAL HYPOTHYROIDISM: AN ONGOING CONUNDRUM
Oriana Hoi Yun Yu, MD

Assistant Professor of Medicine
McGill University
Division of Endocrinology
Jewish General Hospital

Educational Objectives:
1. To discuss the clinical significance of subclinical hypothyroidism
2. To review ongoing research assessing benefits of treating subclinical hypothyroidism
Contact Person: Mark Trifiro, MD, Chief, Division of Endocrinology, Tel. 514-340-8222 ext. 23976.
Press on the “control” key and click on the following link to join this Microsoft Teams meeting:  Join live event

March 1, 2021

PSYCHEDELIC USE IN MEDICINE: THE PAST, THE PRESENT AND THE FUTURE
Elizabeth MacNamara, MD

Associate Professor of Medicine, McGill University
Chief, Division of Medical Biochemistry and Staff Member, Palliative Care Unit, Jewish General Hospital

L. John Hoffer, MD, PhD, FRCPC
Professor of Medicine, McGill University
Division of Internal Medicine and Nutrition Support Team, Jewish General Hospital

& Harvey Chang, MD
Assistant Professor, Faculty of Medicine at McGill University
Medical Team Leader of the Palliative Care Unit, Jewish General Hospital

Educational Objectives:
1. Understand the biological basis and historical origin of psychedelic therapy in clinical medicine
2. Understand the logic, design and outcomes of recent clinical trials of psychedelic therapy
3. Reflect on potential future uses -- and misuses -- of psychedelic therapy
Contact Person: Elizabeth MacNamara, MD, Chief, Division of Medical Biochemistry, Tel. 514-340-8222 x 25091.
Press on the “control” key and click on the following link to join this Microsoft Teams meeting:  Join live event

February 22, 2021

MENTAL HEALTH DURING THE COVID-19 PANDEMIC: EVIDENCE FROM A LIVING SYSTEMATIC REVIEW ON CHANGES IN MENTAL HEALTH AND INTERVENTION EFFECTS
Brett D. Thombs, PhD

Professor, Faculty of Medicine, McGill University
Senior Investigator, Lady Davis Institute of Medical Research, Jewish General Hospital
Canada Research Chair (Tier 1)
Member, College of the Royal Society of Canada
Fellow, Canadian Academy of Health Sciences

Educational Objectives:
1. Participants will understand characteristics of COVID-19 mental health research that influence utility
2. Participants will learn about the impact of COVID-19 on mental health and who has been impacted most
3. Participants will be able to identify strategies and options to support patients with mental health
Contact Person: Ernesto Schiffrin, MD, PhD, Physician-in-Chief, Department of Medicine, Tel. 514-340-7538.

February 15, 2021

NEW APPROACHES FOR CARDIOVASCULAR DISEASE PREVENTION
Jean-Claude Tardif CM, MD, FRCPC, FCCS, FACC, FAHA, FESC, FCAHS

Director, MHI Research Center
Professor of medicine
Canada Research Chair in translational and personalized medicine
Université de Montréal endowed research chair in atherosclerosis
Montreal Heart Institute

Educational Objectives:
1. Review the results of new studies on cardiovascular disease prevention
2. Understand the role of inflammation reduction in coronary disease
3. Learn the effects of omega-3 fatty acids in atherosclerotic cardiovascular disease
Contact Person: Rubin Becker, MD, Chief, Division of Internal Medicine, Tel. 514-340-7596.

February 8, 2021

I. AN INHERITED CASE OF INSUBORDINATE TREMOR
Ève Belzile-Dugas, MD, CM

Internal Medicine Second Year Medical Resident
McGill University and Jewish General Hospital

Educational Objectives:
1. To review an approach to the neuropsychiatric illness
2. To review the clinical manifestations, pathogenesis and diagnosis of Wilson’s disease
3. To review the treatment and prognosis of Wilson’s disease
II. THE HAZZARD OF DUKE'S: ON RIGHT-SIDED ENDOCARDITIS
Wassim Bedrouni, MD
Internal Medicine Third Year Resident
McGill University and Jewish General Hospital
Educational Objectives:
1. On the clinical manifestations, diagnosis and limitations of diagnostic tools for endocarditis
2. Discussing the management of endocarditis, with a focus on the indications for surgical recourse
Contact Person: Elise Levinoff, MD, Jewish General Hospital Site Program Director, Core Internal Medicine Residency at McGill University, Tel. 514-340-8222 poste 24974.

February 1, 2021

THIRTY SECOND ANNUAL HUMANIZATION OF CARE AWARENESS PROGRAM ROUNDS
TO “V” OR NOT TO “V”? VACCINE HESITANCY IN THE AGE OF THE COVID-19 PANDEMIC
Zeev Rosberger, PhD

Associate Professor, Departments of Psychology, Oncology & Psychiatry
Senior Investigator, Lady Davis Institute for Medical Research
Educational Objectives:
1. To understand the challenges in defining “vaccine hesitancy” and examining its prevalence
2. To understand what is known about the psychosocial factors that influence vaccine decision-making
3. To summarize what we know about communication and intervention strategies that work (or not) to mitigate vaccine hesitancy and increase vaccine acceptance
Contact Person: Ms. Rebecca Kaufer, Administrative Coordinator, Humanization of Care Committee, Ext. 21924.

January 25, 2021

PERSPECTIVES ON END-OF-LIFE CARE IN THE ELDERLY
I. The suffering patient
Bruno Gagnon, MD
Associate professor, Department of Family Medicine and Emergency Medicine
Cancer Research Centre, Faculty of Medicine, Université Laval
Educational Objectives:
1. To recognize the various types of suffering and how to explore them
2. Responding to the experience of suffering
&
II. Treatment options around end-of-life suffering
Elizabeth MacNamara, MD
Associate Professor, Department of Medicine, McGill University
Director, Department of Diagnostic Medicine, Jewish General Hospital of CIUSSS COM  
& David Dannenbaum, MD
Faculty Lecturer, Department of Medicine, McGill University
Department of Family Medicine, Jewish General Hospital of CIUSSS COM 
Educational Objectives:
1. Review treatment options to relieve patients with end of life (EOL) suffering
2. Understand the difference between palliative care, palliative sedation and Medical aid in Dying (MAID)
3. Demystify several common myths around MAID
Contact Person: José Morais, MD, Chief, Division of Geriatric Medicine, Tel. 514-340-7501.

January 18, 2021

CURRENT AND EMERGING MOLECULAR TECHNOLOGIES FOR SARS-COV-2 RNA DETECTION: DELIVERY IN 20 MINUTES OR YOUR PIZZA IS FREE
Gerasimos Jerry Zaharatos, MD, FRCPC
Chief, Division of Medical Microbiology
Department of Clinical Laboratory Medicine
OptiLab Montreal - McGill University Health Centre
Associate Professor, Faculty of Medicine
McGill University
Educational Objectives:
Upon completion of this activity, participants should be able to:
1. Summarize current and emerging molecular testing methodologies available for the detection of SARS-CoV-2
2. Understand the pre-analytic factors that can impact the sensitivity and specificity of molecular tests for SARS-CoV-2
3. Explain the advantages and limitations of “batch” testing platforms vs random access, point-of-care and sample-to-result molecular devices for detecting SARS-CoV-2
Contact Person: Karl Weiss, MD, Chief, Division of Infectious Diseases, Tel. 514-340-8222 ext. 28294.

January 11, 2021

ACUTE & INTENSIVE MANAGEMENT OF SEVERE ADULT ANOREXIA NERVOSA
L. John Hoffer, MD, PhD, FRCPC
Professor of Medicine, McGill University
Division of Internal Medicine and Nutrition Support Team Jewish General Hospital
Educational Objectives:
1. Update recent clinical guidelines and offer clinical pearls regarding in-hospital evaluation and management of life-threatening adult starvation disease
2. Explain why immediate nutritional support is essential, and how to implement it to prevent or mitigate severe starvation-induced hypoglycemia
Contact Person: Rubin Becker, MD, Chief, Division of Internal Medicine, Tel. 514-340-7596.

January 4, 2021

No Rounds

December 14, 2020

CONVERGING PATHOMECHANISMS IN PARKINSON DISEASE AND SCHIZOPHRENIA
Hyman M. Schipper, MD, PhD, FRCPC
Professor of Neurology and Medicine, McGill University
Department of Neurosciences and Medicine (Geriatrics), Jewish General Hospital
Educational Objectives:
1. Review salient clinical and biologic features of schizophrenia and Parkinson disease (PD)
2. Review experimental data linking schizophrenia and PD to a single etiopathogenetic continuum
3. Consider potential disease-modifying interventions based on the converging pathomechanisms
Contact Person: Jeffrey Minuk, MD, Chief, Department of Neurosciences, Tel. 514-340-8222 ext. 28770.

December 7, 2020

JGH ICU EXPERIENCE OF THE COVID-19 EPIDEMIC, LESSONS LEARNED AND MORE QUESTIONS
Sandra Dial, MD, MSc
Assistant Professor of Medicine
McGill University
Critical Care Medicine
Jewish General Hospital and Montreal Chest Institute
Educational Objectives:
1. To describe the clinical characteristics of COVID-19 patients requiring critical care
2. To describe the evolution of practice changes that occurred as we gained experience
3. How can we learn from this experience
Contact Person: Paul Warshawsky, MD, Chief, Division of Adult Critical Care, Tel 514-340-7500.

November 30, 2020

THE PHOSPHATE REGULATING HORMONE FGF23: A FRIEND OR A FOE?
Andrew C. Karaplis, MD, PhD, FRCP, FACP

Professor of Medicine, McGill University
Division of Endocrinology
Director, Metabolic Bone Disease and Fracture Prevention Clinics
Jewish General Hospital
Educational Objectives:
Upon completion of this activity, participants should be able to:
1. Describe the role of bone as an endocrine organ and outline the interaction of FGF23 and other calciotropic hormones in the control of phosphate homeostasis
2. Appraise the common clinical signs of FGF23 overactivity to the underlying physiological mechanisms in bone and kidney and formulate a diagnostic approach to the patient
3. Design and execute a therapeutic plan for the patient
Contact Person: Mark Trifiro, MD, Chief, Division of Endocrinology, Tel. 514-340-8222 ext. 23976.

November 23, 2020

SOLVING POST COLONOSCOPY COLORECTAL CANCER
Linda Rabeneck, MD, MPH, FRCPC

Professor of Medicine, University of Toronto
Vice President, Prevention and Cancer Control at Ontario Health
Senior Scientist at the Institute for Clinical Evaluative Sciences (ICES)
Toronto
Educational Objectives:
1. To learn about the risk factors for post-colonoscopy colorectal cancer
2. To understand the benefits of conducting a root cause analysis
3. To learn how to reduce the risk of post-colonoscopy colorectal cancer in practice
Contact Person: Polymnia Galiatsatos, MD, Division of Gastroenterology, Tel. 514-340-8222 x 28144.

November 16, 2020

HODGKIN LYMPHOMA: THERAPEUTIC AND MOLECULAR ADVANCES
Hans Knecht, MD

Professor of Medicine, McGill University
Division of Hematology, Jewish General Hospital
&
Nathalie Johnson, MD
Assistant Professor of Medicine, McGill University
Division of Hematology, Jewish General Hospital
Educational Objectives:
1. Risk adapted therapy and new treatment strategies
2. Deciphering the Reed-Sternberg Cells
Contact Person: Hans Knecht, MD, Chief, Division of Hematology, Tel 514-340-8222 ext. 28799.

November 9, 2020

CANADIAN PATIENT SAFETY WEEK
MEDICATION OVERLOAD: MEDSAFER AS A DEPRESCRIBING ROADMAP
Emily G. McDonald, MDCM, MSc, FRCPC

Assistant Professor of Medicine, McGill University
General Internal Medicine, McGill University Health Center
Director, Clinical Practice Assessment Unit
Director, General Internal Medicine Consult Service
Royal Victoria Hospital
Educational Objectives:
1. Discover how common polypharmacy is in older hospitalized adults
2. Learn about different tools that are available to help manage medication overload 
3. Understand why reducing harmful or unnecessary medications is a top safety priority
4. Highlight the importance of partnering with patients, their family, and the entire multidisciplinary team in discussions related to polypharmacy and medication safety
Contact Person: Chantal Bellerose, Dt. P., B. Sc., M. Sc. Health Adm., Assistant to the Directorate of Quality, Innovation, Evaluation, Performance & Clinical Ethics (DQIEPE), Coordinating Quality, Risk Management, Accreditation, Clinical Ethics User Experience & Planetree, CIUSSS CODIM, Tel. 514-340-8222 ext. 27895.

November 2, 2020

PULMONARY GENETICS: MOVING FROM THE LAB TO THE CLINIC
Benjamin Raby, MD, MPH

Leila and Irving Perlmutter Professor of Pediatrics, Harvard Medical School
Chief, Division of Pulmonary Medicine, Boston Children’s Hospital
Director, Pulmonary Genetics Center, Brigham and Women’s Hospital
Educational Objectives:
1. Learn how genetics influence a variety of common and less common respiratory diseases
2. To understand how genetic information is currently being used for the evaluation and management of patients with a wide range of respiratory diseases
3. To understand how genetic information can play a role in disease detection and early intervention in asymptomatic at-risk relatives of patients with respiratory disease
Contact Person: Carmela Pepe, MD, Division of Pulmonary Medicine, Tel. 514-340-8222 ext. 23636.

October 26, 2020

THE SUCCESS OF A DEDICATED GERIATRIC COVID UNIT AT THE JGH AND BEYOND
Elise Levinoff, MD
Assistant Professor of Medicine, McGill University
Jewish General Hospital Site Program Director Core Internal Medicine Residency at McGill University
Division of Geriatric Medicine, Jewish General Hospital
Educational Objectives:
1. To discuss and review how COVID 19 impacted frailty in geriatric patients
2. A review on the benefits of dedicated geriatric units for patients with COVID 19
3. To further implement AAPA (Approach Adapted to Senior Persons) into the acute hospital setting
Contact Person: José Morais, MD, Chief, Division of Geriatric Medicine, Tel. 514-340-7501.

October 19, 2020

SOMETIMES STEPPING BACK IS BETTER THAN A CLOSER LOOK
Jean L. Bolognia, MD
Professor of Dermatology, Yale School of Medicine
New Haven, Connecticut
Educational Objectives:
1. To appreciate the need to “step back” and have a “low power” view whenexamining the skin
2. To illustrate the concept of a “4X” clinical examination via the differential diagnosis of toxic epidermal necrolysis (TEN)
Contact Person: Robin Billick, MD, Chief, Division of Dermatology, Tel. 514-340-8222 ext. 25065.

October 12, 2020

No Rounds - Thanksgiving

October 5, 2020

Sixth Annual Department of Medicine Clinical Research Symposium
I. PULMONARY ARTERIAL RECRUITMENT AND DISTENSION AND THE ACCOMMODATION OF PULMONARY ARTERIAL FLOW IN FONTAN PATIENT
David Langleben, MD
Professor of Medicine, McGill University
Division of Cardiology, Jewish General Hospital
Educational Objectives:
1. To understand the anatomy and physiology of the Fontan repair, and its dysfunction
2. To understand the potential role of vasodilator therapy in Fontan repair
3. To understand how we assess lung perfusion to answer the above
II. CAN WE MEASURE DAMAGE IN SYSTEMIC SCLEROSIS (SSC, SCLERODERMA)?
Murray Baron, MD
Professor of Medicine, McGill University
Division of Rheumatology, Jewish General Hospital
Educational Objectives:
1. Understand the Concept of Disease Damage versus Activity
2. Learn the value of delphi exercises
3. Learn about the new SSc Damage Index
4. Appreciate the different trajectories of damage in early SSc
III. CAN A BLOOD TEST DIAGNOSIS LUNG CANCER?  
Jason Agulnik, MD
Associate Professor of Medicine, McGill University
Division of Pulmonary Medicine, Jewish General Hospital
Educational Objectives:
1. Understand work-up for advanced Non Small Cell Lung Carcinoma (NSCLC)
2. Understand the different driver mutations for NSCLC

September 28

Yom Kippur - No Rounds

September 21, 2020

NEW ENTITIES IN CANCERS (2018-2020)
Alan Spatz, MD
Professor, Departments of Pathology & Oncology, McGill University
Director, Division of Pathology, McGill University Health Center
Chief, Division of Molecular Genetics, Jewish General Hospital
Educational Objectives:
At the end of the presentation, the participants will:
1. Better understand the importance of phenotype-genotype integration in precision oncology
2. Have a better knowledge of new entities in various fields of solid and hematological cancers
3. Have a better knowledge of the technological opportunities and challenges in oncology
Contact Person:  Ms. Maureen Besley, Division of Pathology, Tel. 514-340-8274.

September 14, 2020

12:30-1:30 PM
SPECIAL EVENT: MEET AND GREET THE RESIDENTS
Elise Levinoff, MD, MSc
Assistant Professor of Medicine, McGill University
Site program Director, Core Internal Medicine Residency
Staff, Division of Geriatric Medicine, Jewish General Hospital
Contact Person: Elise Levinoff, MD, Director, Postgraduate Teaching, Tel. 514-340-8222 x 24974.

September 7, 2020

LABOUR DAY - NO ROUNDS

Page last updated on 

We always seek feedback to make our site better.